Skip to main content
. Author manuscript; available in PMC: 2017 Oct 28.
Published in final edited form as: Bio Protoc. 2017 May 20;7(10):e2292. doi: 10.21769/BioProtoc.2292

Figure 1. BMDMs were primed with LPS and treated for 6 h with vehicle, DMSO (Lane1) Nelfinavir, (Lane 2), lipofectamine (Lipo) (lane 3) Lipofectamine plus poly(dA:dT) (Lane 4), as indicated.

Figure 1

Cross-linked pellets (Pell) or soluble lysates (Lys) were immunoblotted for ASC or caspase-1. More details on the experiment can be found in Di Micco et al., 2016.